FDA Pauses Johnson and Johnson COVID Vaccine After Six Women Developed Blood Clotting Issues

On April 8th the CDC said there were no issues with the Johnson and Johnson vaccine after several people reported reactions in North Carolina. [LINK HERE]

However, less than a week later the FDA is now instructing all medical providers to “pause” the vaccine as six women have developed blood clotting issues.  There have been more than seven million J&J doses administered.

WASHINGTON — Injections of Johnson & Johnson’s single-dose coronavirus vaccine came to a sudden halt in much of the country on Tuesday after federal health agencies called for a pause in the vaccine’s use following the emergence of a rare blood clotting disorder in six recipients.

News anchor freudian slips during a corona vax report that "They are running out of people who want to be euthanized"

 

All six were women between the ages of 18 and 48 and all developed the illness within one to three weeks of vaccination. One woman died and a second woman in Nebraska has been hospitalized in critical condition.

Nearly seven million people in the United States have received Johnson & Johnson shots so far, and about nine million more doses have been shipped out to the states, according to data from the Centers for Disease Control and Prevention.

“We are recommending a pause in the use of this vaccine out of an abundance of caution,” Dr. Peter Marks, director of the Food and Drug Administration’s Center for Biologics Evaluation and Research, and Dr. Anne Schuchat, principal deputy director of the C.D.C., said in a joint statement. “Right now, these adverse events appear to be extremely rare.” (read more)

[embedded content]

.

President Trump implies the FDA relationship with Pfizer may have something to do with the decision.

Source

We have tested 1,500 supposed "covid-19 positive" samples and found none! Only influenza A or B.

Leave a Reply